TET2-mediated upregulation of 5-hydroxymethylcytosine in LRRC39 promoter promotes Th1 response in association with downregulated Treg response in Vogt-Koyanagi-Harada disease

Copyright © 2023 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 250(2023) vom: 01. Mai, Seite 109323
1. Verfasser: Zhang, Wanyun (VerfasserIn)
Weitere Verfasser: Chen, Zhijun, Yi, Kun, Su, Guannan, Liu, Yaning, Deng, Yang, Zhang, Yinan, Cao, Qingfeng, Pu, Yanlin, Luo, Xiang, Lai, Yujie, Yang, Peizeng
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't 5-hmC Autoimmune disease LRRC39 TET2 Transcriptomics VKH disease 5-hydroxymethylcytosine 1123-95-1 mehr... Dioxygenases EC 1.13.11.- DNA-Binding Proteins Forkhead Transcription Factors Interleukin-17 RNA, Messenger TET2 protein, human LRRC39 protein, human